Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 9, 2006, Pages 596-599

  Falagas, M E ^a,b,c   Kasiakou, S K ^c   Kofteridis, D P ^d   Roditakis, G ^d   Samonis, G ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY DUNANT HOSPITAL   (Greece)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; POLYMYXIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; GRAM NEGATIVE BACTERIUM; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; MALE; MORTALITY; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

EID: 33748630508     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0191-2     Document Type: Article

References (14)

1. Navon-Venezia S, Ben Ami R, Carmeli Y (2005) Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18:306-313
2. Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME (2005) Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 49:3136-3146
3. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EA et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008-1011
4. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I et al (2003) Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 7:R78-R83
5. Ouderkirk JP, Nord JA, Turett GS, Kislak JW (2003) Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria. Antimicrob Agents Chemother 47:2659-2662
6. Sobieszczyk ME, Furuya EY, Hay CM, Pancholi P, Della-Latta P, Hammer SM et al (2004) Combination therapy with polymyxin B for the treatment of multidrug-resistant gram-negative respiratory tract infections. J Antimicrob Chemother 54:566-569
7. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D (2003) Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37:e154-e160
8. Berlana D, Llop JM, Fort E, Badia MB, Jodar R (2005) Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health-Syst Pharm 62:39-47
9. Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A (2005) Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 5:1-8
10. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME (2005) Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11:115-121
11. Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G et al (2005) Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31(Suppl 8):1058-1065
12. Wayne P (2000) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standards document M7-A5, Fifth edn. National Committee for Clinical Laboratory Standards, Wayne, PA
13. Gaynes RP, Horan TC (1996) Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayhall CG (ed) Hospital epidemiology and infection control. Williams & Wilkins, Baltimore, pp 1-14
14. Falagas ME, Kasiakou SK (2006) Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob Agents Chemother 50:2274-2275